The number and shape of dendritic spines are influenced by activity and regulated by molecules that organize the actin cytoskeleton of spines. Cortactin is an F-actin binding protein and activator of the Arp2/3 actin nucleation machinery that also interacts with the postsynaptic density (PSD) protein Shank. Cortactin is concentrated in dendritic spines of cultured hippocampal neurons, and the N-terminal half of the protein containing the Arp2/3 and F-actin binding domains is necessary and sufficient for spine targeting. Knockdown of cortactin protein by short-interfering RNA (siRNA) results in depletion of dendritic spines in hippocampal neurons, whereas overexpression of cortactin causes elongation of spines. In response to synaptic stimulation and NMDA receptor activation, cortactin redistributes rapidly from spines to dendritic shaft, correlating with remodeling of the actin cytoskeleton, implicating cortactin in the activity-dependent regulation of spine morphogenesis.
Introduction
Dendritic spines are small protrusions found on dendrites of principal neurons of mammalian brain. Serving as postsynaptic compartments for individual excitatory inputs, spines show rapid movements and shape changes that are influenced by synaptic activity (Fischer et al., 2000; Korkotian and Segal, 2001 ). The structural modifications of spines are believed to represent morphological correlates of synaptic plasticity. The form and motility of spines are determined mainly by the actin cytoskeleton (Matus, 2000) . Understanding the molecular mechanisms that control the actin cytoskeleton of spines therefore should provide insights into the structural plasticity of this postsynaptic compartment.
Cortactin is an F-actin binding protein implicated in the stabilization and branching of actin filaments (Wu and Parsons, 1993; Weed et al., 2000; Uruno et al., 2001; Weaver et al., 2001 ). The F-actin binding site of cortactin has been localized to part of the tandem repeats in the central region of the protein (Weed et al., 2000) . In addition, cortactin binds via its N-terminal acidic domain (NTA) to the Arp2/3 complex that functions in actin polymerization (Weed et al., 2000; Uruno et al., 2001) . Cortactin is thought to bind F-actin and the Arp2/3 actin polymerization machinery simultaneously and thereby facilitate the nucleation of new actin branches at the sides of preexisting actin filaments (Uruno et al., 2001; Weaver et al., 2001) . Cortactin also contains a C-terminal SH3 domain for which several binding partners have been identified (Katsube et al., 1998; Ohoka and Takai, 1998; Dudek et al., 2002; Kinley et al., 2003) , including the Shank family of postsynaptic density (PSD) scaffold proteins Naisbitt et al., 1999) and dynamin (McNiven et al., 2000) . The Shank-cortactin interaction offers a potential link between the postsynaptic NMDA receptor-PSD-95 complex and the actin cytoskeleton of the dendritic spine .
In non-neural cells the cortactin translocates to sites of active actin remodeling in the cell periphery in response to growth factors, adhesion, bacterial invasion, or mechanical stress, all of which induce changes in the shape or motility of cells (Ozawa et al., 1995; Weed et al., 1998; Cantarelli et al., 2000; Lopez et al., 2001; Birukov et al., 2002; Di Ciano et al., 2002) . This translocation requires the Arp2/3-and F-actin binding sites of cortactin (Weed et al., 2000; Di Ciano et al., 2002) .
Here we show that cortactin is concentrated with F-actin in dendritic spines of cultured hippocampal neurons but is redistributed to the dendritic shaft in response to NMDA receptor activation. In neurons deficient in cortactin, spine density is diminished greatly, whereas overexpression of cortactin induces longitudinal growth of spines. Spine targeting of cortactin is mediated primarily by the tandem repeats, with a minor contribution from the NTA domain, and these same domains are also important for promoting spine elongation. These findings indicate a critical role for cortactin in the activity-dependent regulation of spine cytoskeleton.
Materials and Methods
Antibodies and drugs. The following antibodies have been described: rabbit antiserum Shank 56/e , guinea pig Shank anti-serum (Sala et al., 2003) , guinea pig PSD-95 antiserum (Kim et al., 1995) , and mouse monoclonal PSD-95 antibody K28/43 (gift from J. Trimmer, State University of New York, Stony Brook, NY). The following antibodies and fluorescent dyes were purchased from commercial sources: cortactin for immunostaining Santa Cruz Biotechnology, Santa Cruz, CA); bassoon (StressGen, Sidney, Canada); hemagglutinin (HA; Y11, Santa Cruz Biotechnology); myc (9E10, Santa Cruz Biotechnology); monoclonal ␤-galactosidase (Promega, Madison, WI); rabbit ␤-galactosidase (Abcam, Cambridge, MA); GAD-6 (Developmental Studies Hybridoma Bank, Iowa City, IA); PV-28 (Swant, Bellinzona, Switzerland); MAP2 (HM-2, Sigma, St. Louis, MO); anti-mouse and anti-rabbit Alexa 488-and 543-conjugated secondary antibodies, propidium iodide (PI), Hoechst 33342, and rhodamine-phalloidin (Molecular Probes, Eugene, OR).
Pharmacological reagents were purchased from the following sources: AMPA, NMDA, CNQX, APV, TTX, bicuculline, and 4-AP (Sigma); L-glutamic acid (Research Biochemicals, Natick, MA); and jasplakinolide (Molecular Probes).
DNA constructs. All cortactin constructs were generated by PCR with the use of Pfu polymerase (Stratagene, La Jolla, CA) and primers with sequence extensions containing the restriction sites AscI and EcoRI, respectively. For the generation of HA-tagged cortactin deletion mutants the amplified DNA fragments were ligated into the AscI and EcoRI restriction sites of the expression vector pGW1-CMV (British Biotechnology, Oxford, UK) carrying an N-terminal HA tag. Inserts were verified by DNA sequencing. For all constructs except W22A and W22A⌬tandem, murine wild-type cortactin was used as template (gift of J. Thomas Parson, University of Virginia, Charlottesville, VA). For W22A and W22A⌬tandem the clone pJP20 was used as template (kind gift from Xi Zhan, American Red Cross, Rockville, MD). N-terminally tagged myccortactin, green fluorescent protein-cortactin (GFP-cortactin), and GFP-Shank1B (all in pGW1-CMV) were kind gifts from Carlo Sala (CNR Institute of Neuroscience, Milan, Italy). GFP-cortactin in Sindbis virus vector was generated by ligating GFP-cortactin into the XbaI and ApaI restriction sites of the pSinRep5 vector (gift of Sondra Schlesinger, Washington University, St. Louis, MO). For the generation of the shortinterfering RNA construct pSUPERcort300 the following DNA oligonucleotides, 5Ј-gatccccgcactgctcacaagtggacttcaagagagtccacttgtgagcagtgctttttggaaa-3Ј and 5Ј-agcttttccaaaaagcactgctcacaagtggactctcttgaagtccacttgtgagcagtgcggg-3Ј (corresponding to nucleotides 300 -318 of the rat and mouse cortactin sequence with the first nucleotide of the start codon counted as nucleotide 1), were annealed and subcloned into the HindIII and BglII sites of the pSUPER vector (OligoEngine Platform).
Sindbis virus generation. GFP-cortactin in pSinRep5 was linearized by using the restriction enzyme PacI and subsequentially transcribed by using the mMessage mMachine RNA transcription kit (Ambion, Austin, TX) according to the manufacturer's instruction. The virus RNA was electroporated into baby hamster kidney cells cultured in modified Eagle's medium (Invitrogen, San Diego, CA) supplemented with 20% fetal calf serum and nonessential amino acids (Invitrogen). After 2 d of incubation the culture medium containing the Sindbis virus particles was harvested and directly used for infection or stored at Ϫ80°C. The GFP Sindbis virus was a kind gift from Terunaga Nakagawa (Massachusetts Institute of Technology, Cambridge, MA).
Cell culture, transfection, immunostaining, and PI exclusion assay. Hippocampal neuron cultures were prepared from embryonic day 18 -19 rat embryos as described previously (Brewer et al., 1993) . Medium density cultures (ϳ150 cells mm Ϫ2 ) were plated on coverslips (GallardSchlessinger, New York, NY) or glass-bottom dishes (MatTek, Ashland, MA) coated with poly-D-lysine (30 g/ml) and laminin (2.5 g/ml). Cultures were grown in Neurobasal medium (Invitrogen) supplemented with B27 (Invitrogen), 0.5 mM glutamine, and 12.5 M glutamate. For time-lapse studies 10 mM HEPES, pH 7.4, was added to the culture medium before the image acquisition. During the imaging period the neurons were kept in a humidified incubation chamber at 37°C and 5% CO 2 . COS-7 cells were maintained in DMEM supplemented with 10% calf serum and transfected with Lipofectamine (Invitrogen).
Neurons were transfected via the calcium phosphate method (Sala et al., 2001 ). For the short-interfering RNA (siRNA) inhibition experiments the neurons were transfected at 13 d in vitro (DIV13) and for the cortactin and deletion mutant overexpression experiments at DIV10. For the spine-targeting study (see Fig. 2 ) a DNA ratio of 1:10 of cortactin (or cortactin mutant) to ␤-galactosidase was used to obtain low expression levels of cortactin or cortactin mutants.
For all immunostaining experiments except Shank staining the neurons were fixed in 4% formaldehyde/4% sucrose in PBS, pH 7.4, for 10 min at room temperature. For immunostaining of Shank the neurons were fixed either in methanol for 10 min at Ϫ20°C (see Fig. 5 ) or in 1% formaldehyde/4% sucrose in PBS, pH 7.4, for 3 min at room temperature, followed by methanol for 10 min at Ϫ20°C (see Fig. 3 ). Immunostaining was performed as described (Sala et al., 2000) .
For the PI exclusion assay the neurons were labeled with 10 M Hoechst 33342 and 5 g/ml PI for 15 min at 37°C and then fixed in 4% formaldehyde/4% sucrose in PBS, pH 7.4, for 10 min at room temperature.
Microscopy and quantitation. Immunofluorescence images were acquired with a LSM510 confocal microscope system (Zeiss, Oberkochen, Germany) and an Axioplan microscope (Zeiss), using a 63ϫ oil immersion lens. Each image consisted of a z-stack of pictures taken at a depth interval of 0.5-0.8 m and then projected into one image.
Time-lapse images were acquired by using Multi-time software (Zeiss) with a Pascal confocal system (Zeiss) and an Axiovert microscope (Zeiss), using a 100ϫ oil immersion lens. Laser intensity of the argon laser at 488 nm was set to 0.1% for GFP-cortactin and 3% for GFP-Shank1B. Neurons with low expression levels of GFP-cortactin and GFP-Shank1B and relatively normal spine morphology were selected to be able to observe movements of the protein in response to stimulation.
Morphometric measurements were performed with the aid of MetaMorph Software (Universal Imaging, West Chester, PA) and was done in part by a third person who was completely unaware of the experimental conditions. Each experiment was repeated at least three times with independent neuronal preparations. Neurons for morphometric analysis were sampled randomly from each neuronal preparation.
For protrusion density (see Fig. 1 ) the number of protrusions (maximum length, 10 m) was counted for 32-45 neurons (ϳ200 m total dendritic length per neuron). For spine size (see Fig. 3 ) ϳ4000 spines (17-23 neurons) were measured for each culture condition. The length of a spine from the base of the neck to the furthest point on the spine head and the maximal width of the spine head perpendicular to the long axis of the spine neck were measured. For each condition individual density measurements or spine dimensions were grouped first and averaged per neuron; means from multiple individual neurons then were averaged to obtain a mean and SEM for the population of neurons.
For the PI exclusion assay 1096 -1207 nuclei were analyzed from three different coverslips for each experimental condition. The ratio of PI to Hoechst 33342-positive nuclei was calculated for each coverslip and then averaged per coverslip to obtain the mean. Similar cell densities between experimental groups were confirmed by counting the number of Hoechst 33342-positive nuclei per microscopic view. Measurements are given as mean Ϯ SEM, unless otherwise stated. Statistical significance was calculated by comparing the means from multiple neurons per experimental condition with the Mann-Whitney test, unless otherwise stated. Densitometric analysis of immunoblot bands was performed by using Quantity One V4.2.2 software (Bio-Rad, Hercules, CA).
Results

Loss of cortactin causes decrease in spine density
To investigate the role of cortactin in dendritic spine morphogenesis, we used siRNA to knock down specifically the expression of endogenous cortactin in relatively mature cultured hippocampal neurons (DIV16). Three different 19 nucleotide sequences specific for murine and rat cortactin mRNA were tested in plasmid (pSUPER)-based siRNA constructs. In heterologous cells only the sequence corresponding to nucleotides 300 -318 of the rat and mouse cortactin sequence (pSUPERcort300) reduced the expression of cotransfected myc-tagged murine cortactin to 17.94 Ϯ 6.84% of control levels ( Fig. 1 A1) and extinguished the fluorescence intensity of cotransfected GFP-cortactin ( Fig.  1 A2) .
Hippocampal neurons transfected with pSUPERcort300 showed a strong decrease in the staining intensity for cortactin ( Fig.  1 ), but no change in other cytoskeletonassociated proteins such as MAP2 (data not shown). The loss of cortactin immunoreactivity was most obvious in spines ( Fig. 1 B6 ) , where cortactin is highly enriched in mature neurons (Fig. 1 B3) . Associated with the knockdown of cortactin, total protrusion density was reduced by 67% (from 3.77 Ϯ 0.26 to 1.26 Ϯ 0.08 protrusions per 10 m dendrite length; p Ͻ 0.0001, Mann-Whitney test) in pSUPERcort300-transfected neurons. This result implies that cortactin is necessary for the formation or stability of spines. The remaining spines still were enriched for F-actin, as revealed by rhodamine-phalloidin labeling (Fig. 1C6 ), and they contained clusters of the PSD protein PSD-95 ( Fig. 1 D6 ) . However, the density of F-actin and PSD-95 clusters on dendrites of cortactin-deficient neurons was diminished greatly, correlating with the loss of spines.
Domains of cortactin required for spine targeting
To address the molecular basis for the role of cortactin in spine morphogenesis, we first determined which domains of cortactin are required for its targeting to dendritic spines. Neurons were doubly transfected with a series of HA-tagged deletion mutants of cortactin together with ␤-galactosidase (␤-galactosidase immunostaining was used to outline neuronal morphology) (Fig. 2) . Overexpressed wild-type (WT) HA-cortactin accumulated specifically in spines (Fig. 2 A) . Progressive deletions of up to the C-terminal half of the protein, including the SH3 domain (⌬SH3, Fig. 2 B) , the proline-rich domain (⌬proSH3, Fig. 2C ), and the ␣-helical region (NTAtandem, Fig. 2 D) , did not impair the targeting of cortactin to spines.
Thus approximately the N-terminal half of cortactin (NTAtandem) is sufficient for concentration in spines, whereas interaction with Shank and other binding partners of the C terminus, such as dynamin, ZO-1, endothelial cell myosin light chain kinase, WASpinteracting protein (WIP), or CBP90 Katsube et al., 1998; Ohoka and Takai, 1998 The NTA alone, however, was distributed diffusely in dendrites with no enrichment in spines (Fig. 2 E) , indicating that the tandem repeats domain of cortactin is necessary for spine targeting. Deletion of the first 38 amino acids of the NTA domain (⌬NTA, Fig. 2 F) or replacing tryptophan-22 by alanine (W22A, Fig.  2G ), two mutations that abolish cortactin interaction with Arp2/3 (Uruno et al., 2001) , did not prevent the cortactin enrichment in spines. The cortactin mutant that lacks the NTA and tandem repeats domain (⌬NTAtandem), however, was virtually absent from dendrites and spines (Fig. 2 Hb,Hc) and instead accumulated in the nucleus (Fig. 2 Ha) . A similar nuclear localization was observed for the mutants containing only the proline-rich and SH3 domains (proSH3, Fig. 2 I) or the SH3 domain alone (SH3, Fig. 2 J) . Taken together, the data indicate that the tandem repeats are important for cortactin localization in spines.
To support this conclusion, we generated a cortactin mutant with an internal deletion of the tandem repeats (⌬tandem, Fig. 2 K) . This ⌬tandem mutant also mainly targeted to the nucleus (Fig. 2 Ka), but some protein was detected in dendrites ( Fig. 2 Kb) , where it showed only weak enrichment in spines. This result confirms the importance of the tandem repeats but suggests that other domains might contribute in minor manner to the spine targeting of cortactin. Because the NTA domain is the only difference between ⌬NTAtandem (which is virtually absent from dendrites and spines) and ⌬tandem, this additional spine targeting determinant presumably resides in the NTA domain. Consistent with this idea, a "double" mutant lacking the tandem repeats and carrying the W22A point mutation in the NTA (W22A⌬tandem) was targeted primarily to the nucleus (Fig. 2 2 Lc). We never observed any enrichment of W22A⌬tandem in spines.
The fourth repeat within the tandem repeat domains has been shown to be essential for the binding of cortactin to F-actin (Weed et al., 2000) . However, a cortactin mutant lacking repeat 4 (⌬repeat4) still accumulated in spines (Fig.  2 M) . Furthermore, a mutant containing only the tandem repeat region of cortactin (tandem, Fig. 2N ) was distributed diffusely throughout the dendrites and spines, but with no enrichment in spines. We conclude that the tandem repeats domain is necessary, but not sufficient, for the targeting of cortactin to spines. In addition to the tandem repeats, the NTA domain seems to contribute a spine-targeting determinant.
Cortactin promotes longitudinal spine growth
In the spine targeting experiments we noticed that neurons expressing high levels of WT cortactin showed significantly longer spines ( Fig. 3B ) than control neurons expressing ␤-galactosidase alone (Fig. 3A) .
The increase in length appeared to be mainly attributable to increased length of the spine neck. Overexpression of the C-terminal deletion mutants ⌬SH3, ⌬proSH3, or NTAtandem (all of which target efficiently to spines) also resulted in spine elongation, similar in degree to WT overexpression ( Fig. 3C -E,G, Table 1 ). The spine-elongating activity of the C-terminal deletion mutants correlates with the fact that the minimal cortactin fragment required for the promotion of actin polymerization comprises the NTA and tandem repeats domains (Weaver et al., 2001) and suggests that the elongated spines are a result of enhanced actin polymerization. In addition, however, overexpression of these C-terminal deletion mutants also prominently reduced the width of the spine head (Fig. 3F, Table 1 ). Neurons expressing the shortest C-terminal mutant (NTAtandem) had the thinnest protrusions, many of which resembled filopodia in that they lacked a spine head (Fig. 3E,F ) . These data suggest that domains in the C-terminal half of cortactin play a role in the morphogenesis of spines, particularly of the spine head. In addition to the difference from WT cortactin or control, we observed statistically significant differences with regard to spine width among several of the different C-terminal deletion mutants of cortactin (Table 1) , suggesting a contribution of each of the C-terminal domains (␣-helical, proline-rich, and SH3) to the formation of spine heads. The overexpression of WT cortactin did not cause an accumulation of endogenous Shank in spines (Fig. 3H ) , consistent with the observation that the interaction between Shank and cortactin is not required for the localization of the proteins to spines (Sala et al., 2001 ; this study).
Cortactin induces the formation of protrusions in aspiny neurons
Aspiny inhibitory interneurons comprise ϳ5-10% of the neurons in our hippocampal cultures and can be identified by morphological criteria as well as molecular markers such as glutamic acid decarboxylase (GAD; Kunkel et al., 1986; Benson et al., 1994) and various calcium binding proteins, including parvalbumin (Sik et al., 1995; Lee et al., 2000) . Additionally, these interneurons characteristically have elongated F-actin patches (data not shown) and a high density of bassoon puncta along their dendrites (Fig. 4 A2) . Staining with the cortactin antibody showed only weak and diffuse staining (Fig. 4 A1, arrows) , indicating that cortactin is expressed minimally in this type of neuron (for comparison, a dendrite of spiny neuron is indicated by an arrowhead in Fig. 4 A1) .
Interneurons infected with control Sindbis virus expressing GFP showed smooth dendrites with no protrusions (Fig. 4 B1) . However, interneurons (as defined by their typical dendritic morphology and GAD or parvalbumin immunoreactivity in the cell soma (Fig. 4C2,D2 ) infected with GFP-cortactin displayed numerous tiny protrusions resembling short filopodia emerging from the dendritic shaft (Fig. 4 B2,C1,D1) . Interestingly, GFP intensity in these protrusions was higher than in the dendrite, indicating that GFPcortactin was enriched in these structures (Fig. 4 B4 ) . Thus overexpression of cortactin induces the outgrowth of atypical dendritic protrusions in neurons that normally do not form spines.
Cortactin is enriched in dendritic spines and translocates with glutamate stimulation
Spines undergo activity-dependent morphological changes that most likely are based on rearrangements of the underlying actin cytoskeleton (for review, see Matus, 2000; Hering and Sheng, 2001 ). Because cortactin binds to F-actin and affects actin polymerization, we asked whether cortactin changes distribution in response to synaptic activity. In basal conditions of mature hippocampal cultures, labeling with the cortactin antibody H-191 showed numerous immunoreactive puncta along the dendrites of spiny (presumptive pyramidal) neurons ( Fig. 5A1; see also Fig. 1B) . The punctate cortactin staining colocalized with the concentration of F-actin in dendritic spines, as revealed by double labeling with phalloidin (Fig. 5A2,A3 ). Cortactin puncta also showed overlap with the presynaptic protein bassoon (Fig. 5B) , consistent with the postsynaptic enrichment of cortactin. We were unable to demonstrate a colocalization of cortactin and its binding partner Shank because of fixation incompatibility of the respective antibodies.
Bath application of glutamate (100 M) for 15 min to cultured hippocampal neurons led to the disappearance of F-actin from spines and its reappearance as filamentous bundles within the dendritic shaft (Fig. 5A5) , as reported previously (Halpain et al., 1998) . The same glutamate treatment caused a redistribution of cortactin from dendritic spines to a diffuse pattern within dendrites (Fig. 5A4 ) . Similar results also were obtained with lower concentrations of glutamate and with bicuculline treatment (see below), implying that cortactin redistribution is not attributable to excitotoxicity.
The disappearance of cortactin from spines was not attributable to the degradation of the protein, because immunoblot analysis showed unchanged levels of total cortactin in stimulated cultures (data not shown). In contrast to cortactin (Fig. 5B4 ) , the immunostaining patterns of presynaptic protein bassoon and PSD protein Shank remained punctate after 15 min of glutamate stimulation (Fig. 5B5,C1,C2 ). Thus glutamate excitation induces the specific translocation of cortactin from postsynaptic sites in dendritic spines.
To investigate the dynamics of cortactin redistribution, we performed time-lapse imaging of GFPtagged cortactin expressed by Sindbis virus vector in live hippocampal neurons. Exogenous GFP-cortactin accumulated in the heads of dendritic spines (Fig. 6 A, 0 min; red pseudocolor represents high fluorescence intensity), similar to the distribution of endogenous cortactin and transfected HA-cortactin (Figs. 5A1, 2A) . Diffuse GFP-cortactin signal also was observed at much lower intensity in the dendritic shaft. In unstimulated neurons GFPcortactin showed little change in overall distribution (Fig. 6 A, 0 and 6 min). However, glutamate stimulation induced a rapid and dramatic change in the localization of GFP-cortactin. GFP-cortactin fluorescence intensity decreased greatly in spines and increased strongly in the dendritic shaft, implying a redistribution of GFP-cortactin from spines to the shaft (Fig. 6 B, 12-54 min). In some stimulated neurons vacuole-like areas could be seen that were relatively devoid of GFP-cortactin; these structures might reflect early excitotoxicity induced by glutamate (Bindokas and Miller, 1995; Hasbani et al., 2001) . Concomitantly with GFP-cortactin redistribution, the morphology of spines changed, the majority becoming thinner and more elongated. The formation of new filopodia-like protrusions was observed, some of which grew from existing spine heads (Fig. 6 A, arrows) . GFP-tagged Shank1B also concentrated in dendritic spines but, in contrast to GFP-cortactin, showed little change in subcellular distribution after glutamate stimulation (Fig. 6 B) . In transfected neurons GFP-Shank1B was concentrated in spines with weak signal in dendritic shafts (Fig. 6 B, 0 min) , as reported before for HA-tagged Shank1B (Sala et al., 2001) . In live imaging GFP-Shank1B clusters were localized stably to spines in unstimulated neurons (Fig. 6 B, 0 and 6 min), and this distribution did not change after 100 M glutamate application (Fig. 6 B) . These live-imaging data demonstrate that cortactin redistributes from spines within a few minutes of glutamate stimulation, whereas the localization of PSD proteins as represented by Shank remains grossly unchanged.
The direction of cortactin movement (from spines to shaft) contradicts a previous report from our lab in which glutamate stimulation increased cortactin staining at synaptic sites . Although the culture conditions of those experiments and this study are similar, we cannot exclude that some subtle change in culture density or quality under- lies this difference. We suspect, however, that the discrepancy might be attributable to the cortactin monoclonal antibody (4F11) used in Naisbitt et al. (1999) , which we subsequently found recognizes a band around 45 kDa in addition to the 80/85 kDa cortactin doublet on immunoblots (H. H., unpublished observation). The cortactin antibody H-191 used in this study reacts only with the 80/85 kDa bands (H. H., unpublished observation). We believe that cortactin translocation from the spine to the dendrite is correct, because the immunostaining result is corroborated by direct visualization of translocation of GFP-cortactin in live neurons (Fig. 6) .
NMDA receptor-dependent redistribution of cortactin Which type of glutamate receptor mediates the glutamateinduced dispersal of cortactin? Hippocampal neurons stimulated for 15 min with 50 M NMDA (in the presence of 30 M CNQX and 1 M TTX) showed cortactin redistribution from spines ( Fig.  7A1) and rearrangement of F-actin (Fig. 7A2 ) similar to glutamate-stimulated cells. In contrast, specific stimulation of AMPA receptors with 100 M AMPA (plus 100 M APV and 1 M TTX) caused no change in the staining pattern of cortactin (Fig.  7B1 ) or F-actin (Fig. 7B2) . Moreover, the dispersal of cortactin by glutamate was blocked by the NMDA receptor antagonist APV (Fig. 7C) . Taken together, these findings indicate that the translocation of cortactin is induced by the activation of NMDA receptors.
Bath application of glutamate or NMDA stimulates synaptic as well as extrasynaptic NMDA receptors (Hardingham et al., 2002) and can induce excitotoxicity in neurons (Rothman and Olney, 1995; Hardingham et al., 2002) . We therefore stimulated hippocampal neurons with a lower concentration of glutamate (30 M, 15 min). This treatment caused the dispersal of cortactin and the rearrangement of F-actin into dendritic bundles (Fig.  7E1-E3 ) in ϳ95% of the neuronal population, similar to 100 M glutamate. Furthermore, we assessed possible excitotoxic damage to neuronal dendrites by MAP2 staining (Fig. 7H ) . No obvious change in microtubule organization was observed in the majority of dendrites in which cortactin was dispersed after glutamate treatment (Fig. 7H1) . Using the PI exclusion assay, which gives a more quantitative measurement of cellular damage, we found that the ratio of PI-positive nuclei to the total number of nuclei (as detected by Hoechst 33342 staining) was 0.38 Ϯ 0.05 (mean Ϯ SEM) after 24 hr of recovery from treatment with 30 M glutamate for 15 min and was 0.17 Ϯ 0.01 in untreated control neurons. The difference was statistically significant ( p ϭ 0.02, Student's t test), suggesting that an additional ϳ20% of the neuronal population shows signs of cellular damage after glutamate treatment as compared with control neurons. However, this was substantially less than the percentage of neurons (ϳ95%) that shows a redistribution of cortactin and F-actin in response to 30 M glutamate, indicating that the translocation of cortactin is not solely a result of excitotoxicity. The density of cells in control and glutamate treated cultures was similar after 24 hr of recovery (data not shown).
To test whether cortactin redistributes in response to more physiological NMDA receptor activation, we stimulated synaptic activity in hippocampal cultures with 50 M bicuculline and 500 M 4-AP (bic/4AP; Hardingham et al., 2002) . Exposure of neurons to bic/4-AP for 15 min did not cause any obvious changes in the distribution of endogenous cortactin and F-actin (data not shown). However, after 1 hr in the presence of bic/4-AP approximately one-third of the neurons showed loss of cortactin and F-actin from spines (Fig. 7D1,H2 ) and the formation of F-actin fibers in dendrites (Fig. 7D2) . Redistribution of cortactin in the majority of neurons was observed after 24 hr of bic/4-AP treatment (data not shown). Bic/4-AP had no excitotoxic effects on hippocampal neurons as revealed by MAP2 staining (Fig. 7H2) Time-lapse imaging clearly confirmed the bic/4-AP-induced redistribution of GFP-cortactin from spines to dendritic shaft (Fig. 7F ) , although the time course of cortactin translocation was slower than with the bath application of glutamate. We never detected vacuolar swellings in dendrites of neurons treated with bic/4-AP. Thus cortactin mobilization occurs in response to synaptic stimulation in the absence of excitotoxicity.
Both cortactin and F-actin redistribute from spines in response to glutamate stimulation. Is there a possible causal relationship between these events? Treatment of hippocampal neurons with jasplakinolide (2 M), a drug that stabilizes F-actin, did not affect the spine localization of cortactin in unstimulated conditions (Fig. 7G1 ) but prevented the dispersal of cortactin induced by glutamate (Fig. 7G2) . These results suggest that glutamate-induced translocation of cortactin is secondary to the rearrangement of the actin cytoskeleton. The localization of F-actin could not be shown in this experiment, because phalloidin binds to the same site on actin filaments as jasplakinolide.
Discussion
Cortactin and spine morphogenesis During neuronal development long thin filopodia protrude from dendrites and subsequently are replaced by shorter spines with well defined heads in more mature neurons. The emergence of filopodia and spines is presumably the result of the protrusive force of actin polymerization, which is regulated by multiple actin binding proteins (for review, see Cooper and Schafer, 2000) . A variety of actin binding proteins, including neurabin/spinophilin, ␣-actinin, drebrin, synaptopodin, SPAR, and inositol 1,4,5-triphosphate 3-kinase A, has been localized in dendritic protrusions (Nakanishi et al., 1997; Wyszynski et al., 1997; Hayashi and Shirao, 1999; Deller et al., 2000; Pak et al., 2001; Schell et al., 2001 ), but their roles in spine morphogenesis are not clear. We find the actin binding protein cortactin to be enriched in spines. siRNA knockdown of cortactin resulted in a drastic reduction of spine density, and overexpression of cortactin caused an elongation of spines. Thus both gain-and loss-of-function experiments indicate a role for cortactin in spine morphogenesis. How might cortactin act in promoting spine numbers? Cortactin has been shown to delay the debranching of aged actin networks (Weaver et al., 2001) ; thus it may be important for stabilizing the actin cytoskeleton in the spine. In addition, cortactin interacts with and facilitates the function of the Arp2/3 complex, which is involved in the growth of actin networks via branch nucleation. The longitudinal growth-promoting activity of cortactin was localized to the N-terminal half of the protein comprising the NTA and the tandem repeats domains. These are the domains that bind to the Arp2/3 complex and F-actin (Wu and Parsons, 1993; Weed et al., 2000; Uruno et al., 2001) and are essential for the activation of the Arp2/3 nucleation machinery by cortactin (Uruno et al., 2001; Weaver et al., 2001) . Thus the spine-elongating activity of cortactin may be related to the promotion of actin branching via the Arp2/3 complex. Similarly, in non-neuronal cells the Arp2/3 complex is essential for the extension of lamellipodia (Bailly et al., 2001) , where it colocalizes with cortactin (Weed et al., 2000) .
In addition to spine elongation, mutants lacking the C-terminal region of cortactin resulted in thinner spines (shrinkage/loss of spine heads), implicating the C-terminal SH3, proline-rich, and ␣-helical domains in determination of spine structure. Exactly how these domains act in spine morphogenesis remains unclear. The biochemical significance of the ␣-helical domains is not known. The proline-rich region is phosphorylated by a variety of tyrosine and serine/threonine protein kinases (for review, see Weed and Parsons, 2001 ) and also may mediate protein-protein interactions. Of these C-terminal domains, the SH3 is best understood and binds to several proteins, including the Shank family of scaffold proteins in the PSD Naisbitt et al., 1999) . Interestingly, Shank is known to play a role in the maturation and enlargement of spine heads (Sala et al., 2001) . One could speculate, therefore, that the interaction between cortactin and Shank is involved in the establishment of spine head morphology. The functional significance of this interaction is probably not the localization of the two proteins, because spine targeting of Shank and cortactin is independent of the respective cortactin and Shank-binding sites (Sala et al., 2001 ; this study). The cortactin SH3 domain also binds to dynamin, which is implicated increasingly in membrane-actin cytoskeleton interactions and morphogenesis (Orth and McNiven, 2003) , and to WIP, which functions in the regulation of the actin cytoskeleton (Kinley et al., 2003) .
Activity-induced cortactin translocation in spines
In response to glutamate receptor stimulation, cortactin redistributed from dendritic spines, consistent with the idea that it might function in activity-dependent dynamic changes of the actin network. It is conceivable that glutamate receptor signaling leads to the dissociation of cortactin from the spine actin network, thereby facilitating the disassembly of actin filaments. However, arguing against this idea is that jasplakinolide inhibited the glutamate-induced dispersal of cortactin, suggesting that the loss of spine cortactin is secondary to actin depolymerization.
The stimulation of glutamate receptors has been demonstrated to slow down the turnover rate of spine actin (Star et al., 2002) . Therefore, the translocation of cortactin from spines may function in the deactivation of the Arp2/3-based nucleation machinery, thereby decreasing the actin turnover rate in spines.
The translocation of cortactin depends on the activation of NMDA-type of glutamate receptors. Bath application of glutamate induced a much faster redistribution of GFP-cortactin than bicuculline/4-AP, possibly because of differential stimulation of extrasynaptic versus synaptic NMDA receptors, which activate distinct signaling pathways (Hardingham et al., 2002) . Activation of total NMDA receptors induces prompt breakdown of the spine actin cytoskeleton (Halpain et al., 1998) , which could explain the rapid loss of cortactin from spines after the application of glutamate. The stimulation of synaptic glutamate receptors, however, might activate a different set of downstream effectors that reorganize the spine actin cytoskeleton at a slower rate, leading to the gradual changes in spine structure that occur over a time scale of hours (Hosokawa et al., 1995; Engert and Bonhoeffer, 1999; Maletic-Savatic et al., 1999) . The slower mobilization of cortactin might reflect the slower kinetics of actin remodeling under these conditions. Alternatively, the rapid translocation of cortactin induced by bath-applied glutamate may reflect an excitotoxic response of hippocampal neurons (Park et al., 1996; Hasbani et al., 2001) . We cannot rule out that excitotoxic events might contribute to the translocation of cortactin; however, the fact that nontoxic bicuculline/4-AP treatment had a similar effect implies that cortactin redistribution can occur in response to more physiological synaptic stimulation.
Rapid NMDA receptor-dependent redistribution from synaptic clusters also has been reported for the PSD protein Homer1c (Okabe et al., 2001) . Homer family proteins are implicated in the structural organization of the PSD by bridging Shank to metabotropic glutamate receptors, IP3 receptors, and other proteins Tu et al., 1999; Xiao et al., 2000; Sala et al., 2001 ). Interestingly, both cortactin and Homer are Shank-binding proteins, yet the synaptic clustering of Shank itself is acutely unaffected by glutamate stimulation. Thus our findings point toward a relatively stable core within the PSD, comprising proteins such as PSD-95 (Okabe et al., 2001) and Shank, and a more dynamic periphery of interacting proteins such as cortactin and Homer that connect the PSD core to the actin cytoskeleton and signaling proteins.
